Coach vs. Kors: Bat...
Health Care: Health Services
DexCom Inc. (DXCM: NASDAQ)
$10.71 -0.06 | -0.56%
06/04/12 - 09:54 AM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 1.06 | 0.77 | 0.98 |
| Price to Sales (TTM) | 8.98 | 1.97 | 1.42 |
| Price to Book (MRQ) | 7.42 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 8.04 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | -17.70 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -18.70 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 41.80 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 56.80 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 93.19 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 20.77 | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 5.10 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 5.80 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.34 | 0.96 |
| Interest Coverage (TTM) | n.a. | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 55.10 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 36.10 | 59.90 | 47.70 |
| EBITD Margin (TTM) | -52.00 | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | -191.28 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -58.70 | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.57 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 8.70 | 7.00 |
| Return on Assets (TTM) | -39.80 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | -69.50 | 5.20 | 2.50 |
| Return on Investment (TTM) | -47.00 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | -89.70 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 163,719.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | -93,546.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 8.30 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 5.10 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 0.90 | 0.60 | 0.40 |
Portfolios with DXCM
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- UserWatch 1 - Breakout
- ContributorBreakout Stocks Of The Week...
- ContributorBarron's Insider Purchases ...
- UserPART 3 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- Userheld_2long
- Userusa9 Portfolio 1
- UserSyOps Portfolio 1
Latest DXCM Headlines from TheStreet
- 5 Under-$10 Stocks Set to Soar 12.29.11 | 06:12 pm
- DexCom Stock Hits New 52-Week Low (DXCM) 11.21.11 | 10:11 am
- DexCom Stock Hits New 52-Week Low (DXCM) 11.08.11 | 10:11 am
- DexCom Stock Gaps Down On Today's Open (DXCM) 11.03.11 | 09:11 am
- DexCom Stock Hits New 52-Week Low (DXCM) 10.27.11 | 02:10 pm
- DexCom Stock Falls On Unusually High Volume (DXCM) 08.04.11 | 02:08 pm
- DexCom Stock Falls On Unusually High Volume (DXCM) 05.05.11 | 01:05 pm
- DexCom CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.07.10 | 02:11 pm
- Breakout Stocks: SPDR Gold Trust, Netflix 08.16.10 | 03:08 pm
- DexCom, Inc.Q2 2010 Earnings Call Transcript 08.04.10 | 01:08 am
Press Releases for DXCM
- Dexcom To Present At The Deutsche Bank 37th Annual Healthcare Conference - Business Wire 04.26.12 | 08:04 am
- Dexcom Schedules First Quarter 2012 Earnings Release And Conference Call For May 2, 2012 - Business Wire 04.25.12 | 08:04 am
- Dexcom To Present At The Barclays Capital Global Healthcare Conference - Business Wire 03.06.12 | 08:03 am
- DexCom, Inc. Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.23.12 | 04:02 pm
- DexCom, Inc. Announces Acquisition Of SweetSpot Diabetes Care, Inc. - Business Wire 02.23.12 | 04:02 pm
- Dexcom Schedules Fourth Quarter And Full Year 2011 Earnings Release And Conference Call For February 23, 2012 - Business Wire 02.14.12 | 09:02 am
- DexCom And Tandem Diabetes Care Announce CGM Development And Commercialization Agreement - Business Wire 02.02.12 | 08:02 am
- Dexcom To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.03.12 | 04:01 pm
- DexCom To Present At Upcoming Investor Conferences - Business Wire 11.07.11 | 04:11 pm
- DexCom To Present At Upcoming Investor Conferences - Business Wire 11.07.11 | 05:11 am
Partner Headlines for DXCM
- DexCom Misses on EPS, Losses Mount - Analyst Blog - Zacks 05.07.12 | 10:05 am
- UPDATE: Brean Murray Carret Raises Target on DexCom to $13.50 - Benzinga 02.24.12 | 04:02 pm
- UPDATE: Wunderlich Securities Raises Price Target on DexCom to $15 - Benzinga 02.24.12 | 09:02 am
- UPDATE: Feltl & Co Upgrades DexCom from Hold to Buy and Lowers PT from $15.85 to $15.35 - Benzinga 08.16.11 | 09:08 am
- DexCom Reaffirmed Neutral - Analyst Blog - Zacks 05.26.11 | 06:05 pm
- Contrarian Ideas: 20 Healthcare Stocks With Low Put/Call Ratios - Seeking Alpha 01.18.11 | 07:01 am
- DexCom shares plunge after FDA seeks more data on products - Reuters 11.05.10 | 12:11 pm
- William Blair Reiterates Outperform on DexCom (DXCM) - Benzinga 08.04.10 | 09:08 am
- M&A Market: Potential Acquisition Plays in Each Sector - Seeking Alpha 07.06.10 | 06:07 am
- DexCom Misses Zacks Consensus - Analyst Blog - Zacks 05.13.10 | 02:05 pm
